Run Zhang Shi

Clinical Associate Professor, Pathology

Clinical Focus

Pathology
Clinical immunology lab
Therapeutic drug monitoring
Steroid hormones
Tumor markers
Infecious disease serology
Trace and toxic elements
Clinical diagnostic protein electrophoresis
Allergy tests
Quality improvement, quality control, quality assurance

Academic Appointments

Clinical Associate Professor, Pathology

Projects

Steroid testing by LC tandem mass spectrometry

Location

CA

Professional Education

Fellowship: Medical College Of Wisconsin (2006) WI
PhD Training: University of Sydney (1996) Australia
Board Certification: American Board of Clinical Chemistry, Clinical Chemistry (2008)
Ph.D., The University of Sydney, Biochemistry (1997)
M.D., Shanghai Medical University, Medicine (1987)

Contact

Academic rzshi@stanford.edu Tel: (650) 725-2080

Alternate Contact rzshi@stanford.edu Tel: 650-725-2080

Clinical (Primary)

This is the primary clinic for this clinical provider. For additional clinical locations and information, please visit the link(s) listed below in the 'Additional Clinical Info' section.

Stanford Clinical Lab at Hillview 3375 Hillview Ave Ste 2101 MC 5627 Palo Alto CA 94304 Tel: (650) 725-2080 Fax: (650) 724-8280

Additional Clinical Info

Current Research and Scholarly Interests

Clinical chemistry and therapeutic drug monitoring;
adult and pediatric clinical endocrine testing;
screening, detection and follow up of multiple myeloma;
tumor markers;
clinical utility of tandem mass spectrometry and high resolution mass spectrometry.

Clinical Trials

Chromogranin A as Blood Marker in Cancer Patients Not Recruiting
More
Gastroentero-pancreatic neuroendocrine tumors (GEP-NETs) are a heterogenous group of neoplasms that arise from enterochromaffin cells of the gastrointestinal (GI) tract and pancreas. They account for 50-70% of all incident NETs. Due to the lack of symptoms in the early stage of disease and the frequency of nonspecific GI symptoms, GEP-NETs are difficult to diagnose. Identification of effective biomarkers (such as Chromogranin A) to improve GEP-NET diagnosis, as well as to assess treatment efficacy, relapse and prognosis, is important for improving outcomes for patients with GEP-NETs. The purpose of this study is to validate the performance of Brahms (BRAHMS) Chromogranin A II Kryptor (KRYPTOR) assay to monitor the course of disease in patients with well-defined GEP-NETs.

Stanford is currently not accepting patients for this trial. For more information, please contact Kathleen Hornbacker, 650-721-4108.
Lead Sponsor
Stanford Investigators
- Shagufta Shaheen
- Run Zhang Shi
View full details

2023-24 Courses

Independent Studies
- Directed Reading in Pathology
  PATH 299 (Aut, Sum)
- Early Clinical Experience in Pathology
  PATH 280 (Aut, Sum)
- Graduate Research
  PATH 399 (Aut, Sum)
- Medical Scholars Research
  PATH 370 (Aut, Sum)
- Undergraduate Research
  PATH 199 (Aut, Sum)

All Publications

Profiles With Related Publications

close
Ash A. Alizadeh, MD/PhD

Moghadam Family Professor
Clinical Focus
Cancer > Lymphoma, Lymphoma, B-Cell Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Burkitt Lymphoma, Follicular Lymphoma, Diffuse Large-Cell Lymphomas, Leukemia, Hairy Cell, Lymphoma, B-Cell, Marginal Zone, Hodgkin Disease, Medical Oncology
Research Interests
My research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.

Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials.

401 Total Publications
close
Raffick A.R. Bowen

Clinical Professor, Pathology
Clinical Focus
Clinical Biochemistry, Clinical Pathology
Research Interests
My current research involves the investigation of immunoassay interferences from blood collection tube additives; particularly, silicone surfactants.

56 Total Publications
close
Linda Boxer, MD, PhD

Vice Dean of the School of Medicine and Stanley McCormick Memorial Professor
Research Interests
Regulation of expression of oncogenes in normal and malignant hematologic cells.

84 Total Publications
close
Patrick O. Brown

Professor of Biochemistry, Emeritus
Research Interests
Dr. Brown, currently an emeritus professor, is founder of Impossible Foods, a company dedicated to replacing the world's most destructive technology - the use of animals to transform plant biomass into meat, fish and dairy foods - by developing a new and better way to produce the world's most delicious, nutritious and affordable meats, fish and dairy foods directly from plants. Visit impossiblefoods.com for more information. He is also founder and president of the Impossible Foundation.

319 Total Publications
close
Gary Dahl

Professor of Pediatrics (Hematology/Oncology), Emeritus
Research Interests
Hematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins.

171 Total Publications
close
Yanan Feng

Sr. Research Scientist - Basic Life, Genetics

10 Total Publications
close
Benjamin Lewis Franc

Clinical Professor, Radiology - Rad/Nuclear Medicine
Clinical Focus
Nuclear Radiology

104 Total Publications
close
Uta Francke

Professor of Genetics and of Pediatrics, Emerita
Clinical Focus
Neurogenetics, Clinical Genetics, Marfan syndrome, Williams syndrome, Heritable connective tissue disorders
Research Interests
Functional consequences and pathogenetic mechanisms of mutations and microdeletions in human neurogenetic syndromes and mouse models. Integration of genomic information into medical care.

564 Total Publications
close
Andrew Gentles

Assistant Professor (Research) of Pathology, of Medicine (BMIR) and, by courtesy, of Biomedical Data Science

115 Total Publications
close
William Greenleaf

Professor of Genetics
Research Interests
Our lab focuses on developing methods to probe both the structure and function of molecules encoded by the genome, as well as the physical compaction and folding of the genome itself. Our efforts are split between building new tools to leverage the power of high-throughput sequencing technologies and cutting-edge optical microscopies, and bringing these technologies to bear against basic biological questions by linking DNA sequence, structure, and function.

174 Total Publications
close
Andrei Iagaru

Professor of Radiology (Nuclear Medicine)
Clinical Focus
Positron-Emission Tomography, Nuclear Radiology
Research Interests
Current research projects include:
1) PET/MRI and PET/CT for Early Cancer Detection
2) Targeted Radionuclide Therapy
3) Clinical Translation of Novel PET Radiopharmaceuticals;

415 Total Publications
close
Nikolaus Jahn

Postdoctoral Scholar, Pathology

13 Total Publications